Le Lézard
Classified in: Health
Subjects: SVY, TDS

Encore Medical Education announces publication of the Official Best of SABCS® News Highlights summarizing key trial results from the 2022 SABCS®


Best of SABCS® News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide.

SAN ANTONIO, Dec. 1, 2022 /CNW/ -- Encore Medical Education, a US-based medical education company will launch the 2022 edition of the Best of SABCS® News Highlights program from the 2022 San Antonio Breast Cancer Symposium (SABCS®) starting December 7th.

This official SABCS® News Highlights program reached more than 5,000 health care professionals in 2021 from over 50 countries. "Excellent recap of the wide variety of presentations from SABCS®. This is such a dense conference that these summary presentations are almost mandatory" said a user who registered in 2021 for program. "The presentations included in these highlights discuss hot scientific topics by experts in the field. The most updated findings are also provided giving great insights regarding the potential advancements in the clinical setting," said another registered user.

A stellar faculty will present their key takeaways with selected original slides from the major trials from #SABCS22 including:

The first expert video highlights will be available starting December 7th at 4PM Central Time (GMT -6 hours). Register today at https://bestofsabcsnews.com/#/home/register and to get daily updates on the most relevant advances in breast cancer via email.

The Best of SABCS® News Highlights is intended for all healthcare professionals including academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as patient advocates and other appropriate health care professionals.

About Best of SABCS® programs

The San Antonio Breast Cancer Symposium®, now in its 45th year, is the premier conference for basic, translational, and clinical cancer research professionals

Best of SABCS® programs offer professionals the opportunity to experience and discuss the most current research and advances in the field of breast cancer with colleagues and key opinion leaders with access to the original presentations and posters.

For information on Best of SABCS® opportunities, please contact Encore Medical Education LLC at [email protected]

Video - https://www.youtube.com/watch?v=A49ituFmMVw&feature=youtu.be
Logo - https://mma.prnewswire.com/media/1959278/SABCS_Logo.jpg

SOURCE Encore Medical Education


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: